Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Long-Term Effects of Antiseizure Medications

View through CrossRef
AbstractMost patients with epilepsy will benefit from seizure control with one of an array of chronic antiseizure medications. Knowledge of the potential long-term effects of these medications is critical to prevent adverse consequences on overall health. Antiseizure medications vary in their capacities to affect the brain and peripheral nerves, hormones, bone mineralization, cardiovascular risk, renal health, hepatic, hematological, and dermatological systems. Understanding of pathophysiology and population risk has evolved, although most of the data available are still on older generation antiseizure medications such as phenytoin, carbamazepine, and valproic acid. The enzyme-inducing properties of some antiseizure medications make their effects on cardiovascular risk and bone health detrimental. Few clear guidelines exist for monitoring long-term effects of medication therapy for epilepsy. When selecting an antiseizure medication, consideration should be given to the individual patient's risks of adverse consequences on other organ systems. During monitoring of patients on chronic therapy, screening tools such as metabolic panels and bone density measurements can help stratify risk and guide management.
Title: Long-Term Effects of Antiseizure Medications
Description:
AbstractMost patients with epilepsy will benefit from seizure control with one of an array of chronic antiseizure medications.
Knowledge of the potential long-term effects of these medications is critical to prevent adverse consequences on overall health.
Antiseizure medications vary in their capacities to affect the brain and peripheral nerves, hormones, bone mineralization, cardiovascular risk, renal health, hepatic, hematological, and dermatological systems.
Understanding of pathophysiology and population risk has evolved, although most of the data available are still on older generation antiseizure medications such as phenytoin, carbamazepine, and valproic acid.
The enzyme-inducing properties of some antiseizure medications make their effects on cardiovascular risk and bone health detrimental.
Few clear guidelines exist for monitoring long-term effects of medication therapy for epilepsy.
When selecting an antiseizure medication, consideration should be given to the individual patient's risks of adverse consequences on other organ systems.
During monitoring of patients on chronic therapy, screening tools such as metabolic panels and bone density measurements can help stratify risk and guide management.

Related Results

Antiseizure medications in critical care: an update
Antiseizure medications in critical care: an update
Purpose of review Seizures and status epilepticus are very common diagnoses in the critically ill patient and are associated with significant morbidity and mortality. T...
Psychiatric Implications of Anti-seizure Medications in Epileptic Population
Psychiatric Implications of Anti-seizure Medications in Epileptic Population
Abstract BACKGROUND AND OBJECTIVE: Epilepsy is a common neurological complaint that is impacting millions of people worldwide. It's linked with a high frequency of psychiat...
Longitudinal exposure to antiseizure medications shape gut-derived microbiome, resistome, and metabolome landscape
Longitudinal exposure to antiseizure medications shape gut-derived microbiome, resistome, and metabolome landscape
Abstract The influence of chronically administered host-targeted drugs on the gut microbiome remains less understood compared to antibiotics. We investigated repetit...
Long-term care needs and hospitalization costs with long-term care insurance: a mixed-sectional study
Long-term care needs and hospitalization costs with long-term care insurance: a mixed-sectional study
BackgroundWith the rapid aging of the population, the health needs of the older adult have increased significantly, resulting in the frequent occurrence of the “social hospitalizat...
A review of suicidality in nonpsychotropic medications
A review of suicidality in nonpsychotropic medications
Abstract Introduction The term suicidality describes the multitude of behaviors related to suicide: suicidal ideation, self-inju...
MO822POLYPHARMACY NEGATIVELY AFFECTS HEALTH-RELATED QUALITY OF LIFE IN DIALYSIS PATIENTS
MO822POLYPHARMACY NEGATIVELY AFFECTS HEALTH-RELATED QUALITY OF LIFE IN DIALYSIS PATIENTS
Abstract Background and Aims Dialysis patients are often prescribed a large number of medications to improve metabolic control a...
Patient Engagement Survey Regarding Future Double-Blinded, Randomized Controlled Trial of Tapering of Chronic Opioid Therapy
Patient Engagement Survey Regarding Future Double-Blinded, Randomized Controlled Trial of Tapering of Chronic Opioid Therapy
Objective: There is a lack of evidence regarding tapering opioid medications in patients with chronic non-cancer pain. The purpose of this survey was to gather perspectives on futu...
Relabeling the Medications We Call Antidepressants
Relabeling the Medications We Call Antidepressants
This paper raises the question about whether the data on the medications we call antidepressants justify the label of antidepressant. The authors argue that a true antidepressant s...

Back to Top